The UK Competition and Markets Authority (CMA) has said that if Stryker Corp.’s purchase of Wright Medical Group NV went ahead, it would have a negative impact on patients in the UK who need ankle replacements. Following an initial investigation, the CMA found that the proposed merger would result in the combined company having a share of over 90% of the total ankle replacement prostheses market in the UK.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?